Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Epidemiology of atrial fibrillation Atrial Stressors ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by